Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (ATNM)

$1.15 0.02 (1.71%)

20:00 EST ATNM Stock Quote Delayed 30 Minutes

ATNM Stock Earnings: Actinium Pharmaceuticals Beats EPS for Q2 2024

By InvestorPlace Earnings Aug 6, 2024

ATNM stock results show that Actinium Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.

3 Under-$10 Biotech Stocks That Could Make You Rich

3 Clinical-Stage Biotech Stocks to Buy for Multibagger Returns

Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024

Volume:

Previous Close -

Market Cap 24.53M

PE Ratio -0.76

EPS -1.51

Volume (Avg. Vol.) 140,123

Day's Range $1.12 - $1.20

52-Week Range $1.07 - $10.24

Dividend & Yield N/A (N/A)

ATNM Stock Predictions, Articles, and Actinium Pharmaceuticals, Inc. (Delaware) Common Stock News

Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar

By Faisal Humayun, InvestorPlace Contributor Jun 7, 2024

These are the biotech stocks to buy for a meme rally as they represent companies with positive impending news related to clinical trials.

3 Cheap Biotech Stocks to Buy Now: May 2024

By Chandler Capital, InvestorPlace Contributor May 14, 2024

Many of these cheap biotech stocks are on their way to achieving FDA approval for their drugs to enter the market.

ATNM Stock Earnings: Actinium Pharmaceuticals Beats EPS for Q1 2024

By InvestorPlace Earnings Apr 29, 2024

ATNM stock results show that Actinium Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.

Biotech on a Budget: 7 Stocks Under $10 With Huge Potential

By Josh Enomoto, InvestorPlace Contributor Apr 15, 2024

The broader medical therapeutic sector is already volatile so it stands to reason in some sense to consider under-$10 biotech stocks. Imagine you acquired shares…

High-Risk, High-Reward: Little-Known Biotech Stock ATNM Could Soar on Breakthrough Cancer Treatment

By David Moadel, InvestorPlace Contributor Mar 15, 2024

ATNM stock offers moonshot or crash-landing possibilities as Actinium Pharmaceuticals works relentlessly to advance life-changing treatments.

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory

By Josh Enomoto, InvestorPlace Contributor Feb 25, 2024

While targeting the therapeutic side of the healthcare sector can be quite lucrative, nothing matches the excitement of biotech penny stocks. Of course, the excitement…

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Feb 21, 2023

It's time to start another day of trading with a breakdown of the biggest pre-market stock movers traders need to know about for Tuesday!

Actinium (ATNM) Stock Pops on Positive Trial Results

By William White, InvestorPlace Writer Oct 31, 2022

Actinium Pharmaceuticals (ATNM) stock is gaining on Monday after posting positive results from a Phase 3 clinical trial.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Oct 31, 2022

Welcome back and get ready for another week of trading as we break down the biggest pre-market stock movers for Monday morning!

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (ATNM)

ATNM Stock Earnings: Actinium Pharmaceuticals Beats EPS for Q2 2024

3 Under-$10 Biotech Stocks That Could Make You Rich

3 Clinical-Stage Biotech Stocks to Buy for Multibagger Returns

Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (ATNM)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

ATNM Stock Predictions, Articles, and Actinium Pharmaceuticals, Inc. (Delaware) Common Stock News

Subscriber Sign in